- Home
- Products
- Customized FluoroAb™
- VEGFA
- Anti-VEGFA MAb (Clone 6)-iFluor® 460 Succinimidyl Ester
Anti-VEGFA MAb (Clone 6)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9235)
This product is comprised of an Humanized Anti-VEGFA scFv-kappa-heavy (Clone 6) labeled with iFluor® 460 Succinimidyl Ester. iFluor® 460 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- VEGFA
- Alternative Names
- MVCD1; Vascular permeability factor; VEGF-A; VPF; VEGF; Vascular endothelial growth factor A
- Overview
- VEGF is an angiogenic growth factor and a prognostic indicator for cancer when detected in serum. VG-1 is useful for studies of VEGF and angiogenesis in human pathological material.
- Overview
- Humanized Anti-VEGFA scFv-kappa-heavy (Clone 6)
- Species Reactivity
- Human
- Name
- iFluor® 460 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 468/493
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-PDCD1 MAb (Clone 15)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15304)
- Anti-EPCAM MAb (Clone 6)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12903)
- Anti-C-kit MAb (Clone 8)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6426)
- Anti-CD22 MAb (Clone 5)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8019)
- Anti-ITGB2 MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13679)
- Keliximab-iFluor 555 (CAT#: ADC-FL-654)
- Anti-CD19 MAb (Clone 17)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14765)
- Rilotumumab-iFluor 647 (CAT#: ADC-FL-1593)
- Anti-TNFRSF9 MAb (Clone 10)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1530)
- Anti-IL17A MAb (Clone 3)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16172)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS9235. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2293 | Anti-VEGFA (Vanucizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-1931 | Anti-VEGFA (Bevacizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-1937 | Anti-VEGFA (Ranibizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-1932 | Anti-VEGFA (Bevacizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-2290 | Anti-VEGFA (Vanucizumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
